Skip to content

Asset turnover at other companies

Procter & Gamble logo
Procter & GamblePG
0.7×0.0×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.5×0.0×
HRO
HarrowHROW
0.7×0.0×
Cencora logo
CencoraCOR
4.3×-0.3×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.4×0.0×
Cardinal Health logo
Cardinal HealthCAH
4.7×+0.1×

Other financials

Income statement

See full
Revenue$281.6M-5.0%
Gross profit$146.3M-13.9%
Operating income$75.5M-14.6%
Net income$53.9M+7.6%
EPS (diluted)$1.13+11.9%

Balance sheet

See full
Cash & equivalents$63.9M-34.8%
Total debt$1.0B-0.2%
Total equity$1.9B+2.9%
Total assets$3.5B+2.7%

Cash flow

See full
Operating cash flow$42.8M-30.7%
CapEx$5.2M+49.8%
Free cash flow$37.6M-35.5%

Valuation

See full
Market cap$2.18B-34.1%
Enterprise value$3.16B-27.3%
P/E11.5×-4.0×
P/S-0.9×

Profitability

See full
Gross margin54.7%-1.1pp
Operating margin28.4%-1.2pp
Net margin17.5%-1.4pp
FCF margin22.6%+1.3pp

Returns & leverage

See full
Return on equity10.2%-2.1pp
Debt / equity0.6×0.0×
Current ratio3.6×-0.6×

Where this comes from

Calculated from Prestige Consumer Healthcare’s reported figures.

Based on trailing twelve months.

The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prestige Consumer Healthcare's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prestige Consumer Healthcare's asset turnover?
Prestige Consumer Healthcare (PBH) reported asset turnover of 0.3× in Q1 2026.
How has Prestige Consumer Healthcare's asset turnover changed year-over-year?
Prestige Consumer Healthcare's asset turnover decreased by 6.8% year-over-year, from 0.3× to 0.3×.
What is the long-term trend for Prestige Consumer Healthcare's asset turnover?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's asset turnover has grown at a 3.0% compound annual growth rate (CAGR), from 0.3× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.